Cannabinoid and Psychedelic Pharmacology and Drug Development

This podcast episode explores Quality by Design (QbD) principles in pharmaceutical development, with a special focus on cannabinoid and psychedelic drug manufacturing. The discussion covers the three cornerstone ICH guidelines (Q8, Q9, Q10) and how they enable building quality into medicines from the start rather than just testing final products. The episode delves into practical applications thro...

This podcast episode explores phase-appropriate drug development, detailing how testing and validation requirements evolve from early to late-stage clinical trials. It covers the progression from Phase 1's initial safety focus and limited process validation to Phase 2's more comprehensive analytical testing and critical process parameters. The discussion emphasizes how Phase 3 requires rigorous pr...

This podcast episode provides a comprehensive overview of ICH (International Council for Harmonization) guidelines and their application to cannabinoid and psychedelic drug development. The discussion covers the fundamental aspects of ICH guidelines, including: - The Q series focusing on Good Manufacturing Practices (GMP) and quality control - Safety (S) and Efficacy (E) modules for ensuring drug...

This podcast episode provides a comprehensive overview of the FDA drug development process for cannabinoid and psychedelic therapeutics. The hosts discuss the journey from pre-clinical research through post-marketing surveillance, explaining key stages including: - Pre-clinical research and molecular interactions with brain receptors - The IND (Investigational New Drug) application process - The t...

This introductory episode of a 30-day podcast series explores FDA drug development through the lens of cannabis and psychedelic therapeutics. The conversation covers fundamental concepts including cGMP (current good manufacturing practices), ICH guidelines, quality by design, and label accuracy. The hosts emphasize how these regulations ensure drug safety and efficacy while addressing the unique c...

This podcast episode discusses the FDA's recent rejection of Lykos's MDMA application for PTSD treatment. The conversation explores the FDA's key concerns, including the need for more long-term data and research on drug interactions. The hosts delve into challenges like designing effective placebo trials, the role of personalized medicine, and the importance of understanding individual variations...

This podcast episode offers an in-depth exploration of Alexander Shulgin's life and contributions to psychedelic research. The discussion covers his groundbreaking work in synthesizing and documenting numerous psychedelic compounds, including MDMA and 2C-B. The episode highlights Shulgin's innovative approach to structure-activity relationships (SAR), his meticulous self-experimentation methods, a...

A fascinating and engaging quiz show-style podcast episode about psychedelic pharmacology. The episode features an expert PhD researcher who breaks down complex topics into digestible information, covering key areas such as: - The role of specific receptors like 5HT2A in psychedelic effects - How ketamine affects brain connectivity - The science behind psilocybin's long-lasting effects on neuropla...

This podcast episode presents an engaging and accessible exploration of psychedelic pharmacology in a quiz show format. The hosts break down complex scientific concepts about how psychedelics interact with the brain, focusing on key topics like receptor binding, neuroplasticity, and therapeutic applications. The discussion covers various substances including psilocybin, ketamine, and MDMA, examini...

This podcast episode serves as a thoughtful reflection on a 30-day deep dive into psychedelic pharmacology. The hosts discuss key concepts like receptor pharmacology, comparing psychedelics to keys that fit specific locks in the brain. They explore how different substances like LSD, psilocybin, and MDMA interact with brain receptors, particularly focusing on the important 5HT2A receptor. The conve...

This podcast episode explores the future of psychedelic therapy, focusing on personalized medicine and innovative delivery methods. Key topics include: - The role of AI in drug discovery and receptor modeling - New delivery methods like transdermal patches and nasal sprays for controlled dosing - The importance of set and setting in therapeutic outcomes - The interaction between MDMA and various s...

This podcast episode explores the legal and regulatory landscape of psychedelic research, covering the historical evolution from the 1950s boom through the restrictive Controlled Substances Act to today's changing environment. The discussion delves into receptor pharmacology, particularly focusing on how 5HT2A receptors influence legal classifications. It also examines promising developments in no...

This podcast episode explores how animal studies help us understand psychedelic effects in humans, with a particular focus on receptor homology and the "lock and key" system of 5HT2A receptors. The discussion covers key research findings about MDMA, including temperature sensitivity and multiple receptor interactions, as well as LSD's effects on brain activity and consciousness. The episode also d...

This podcast episode explores the long-term effects of psychedelics on the brain, discussing key concepts like receptor-mediated neuroplasticity and the importance of set and setting. The conversation covers various substances including MDMA, LSD, and ayahuasca, examining both their therapeutic potential and possible risks. Important topics include: - The role of BDNF in brain plasticity and neura...

This podcast episode explores the therapeutic potential of psychedelics in oncology, particularly focusing on how substances like psilocybin and MDMA can help cancer patients manage existential distress and improve quality of life. The discussion covers key topics including: - The importance of set and setting in psychedelic therapy - The role of the 5-HT2A receptor in emotional regulation and fea...

This podcast episode explores the fascinating relationship between psychedelics and neuroinflammation, focusing on how these substances interact with the brain's immune system. The discussion delves into the role of the serotonin 5HT2A receptor and microglia in regulating inflammation, and how psychedelics might help treat conditions like depression and neurodegenerative disorders. The episode als...

This podcast episode explores the safety and toxicology of psychedelic substances, with a particular focus on MDMA and LSD. The discussion covers key mechanisms of action through the 5HT2A receptor, potential risks like neurotoxicity and serotonin syndrome, and the importance of careful monitoring in clinical settings. The episode delves into how different psychedelics interact with the brain, inc...

This podcast episode explores non-hallucinogenic serotonin agonists, a promising new direction in psychedelic research. The discussion focuses on compounds that can potentially deliver therapeutic benefits of psychedelics without causing hallucinations, with particular attention to Psilera's PSIL-006 compound. The conversation covers key topics including: - How these compounds work through partial...

This episode explores the fascinating connection between the gut microbiome and psychedelic therapy. The discussion delves into how trillions of gut bacteria might influence the effectiveness of psychedelic treatments through their production of metabolites and interaction with serotonin systems. Key topics include the role of the 5-HT2A receptor in psychedelic effects, MDMA's therapeutic potentia...

This podcast episode explores how psychedelics like psilocybin and MDMA enhance psychotherapy through their effects on brain chemistry and neural pathways. The discussion covers key mechanisms including the 5HT2A receptor, oxytocin release, and connections between the amygdala and prefrontal cortex. The speakers examine how these substances can promote synaptic plasticity and fear extinction, part...

In this fascinating episode about novel formulations in psychedelic science, we explore cutting-edge developments in making psychedelic treatments safer and more effective. Key topics include pro-drugs designed for targeted delivery, non-hallucinogenic analogs that maintain therapeutic benefits without intense psychedelic effects, and innovations in dosage control and delivery methods. The discuss...

This podcast episode explores the controversies and challenges in psychedelic science, covering key topics including: - MDMA-assisted therapy's potential for PTSD treatment and psilocybin's promise for treatment-resistant depression - The importance of set, setting, and positive intentions in psychedelic experiences - The role of 5-HT2A and NMDA receptors in psychedelic effects, including potentia...

This podcast episode explores the complex challenges of blinding in psychedelic research studies. The discussion delves into why traditional blinding methods often fall short when studying substances like MDMA, LSD, and DMT. Key topics include: - The role of physical indicators like body temperature changes in MDMA studies - How different psychedelics interact with 5HT2A receptors through "functio...

This podcast episode explores non-serotonergic mechanisms of psychedelics, particularly focusing on ketamine and DMT. The discussion delves into how these substances work beyond traditional serotonin pathways, examining their interactions with NMDA and Sigma-1 receptors. The episode covers the fascinating relationship between ketamine and brain connectivity, neuroplasticity, and its potential ther...

This podcast episode explores the fundamental concept of "set and setting" in psychedelic experiences, discussing how both internal mindset and external environment influence therapeutic outcomes. The conversation delves into the scientific mechanisms behind these effects, including how 5-HT2A receptors and the default mode network interact with environmental factors. The discussion includes insig...